Your trust manufacturer: 2-(2-(2-Aminoethoxy)ethoxy)acetic Acid (AEEA): A High-Purity Linker for Advancing Global Peptide Drug Development
Publish Time:
2025-09-22
CongenPharma specialize in the production of 2-(2-(2-Aminoethoxy)ethoxy)acetic acid (AEEA) (CAS: 134978-97-5).
Leveraging our advanced R&D and manufacturing platform, we have achieved large-scale production with high purity (≥99%, up to nearly 100%), meeting the stringent requirements of global pharmaceutical companies.
As a critical linker in peptide drug development, this product is widely applied in the synthesis of Semaglutide, Tirzepatide, and other next-generation peptide-based therapeutics, providing reliable support for global pharmaceutical innovation.
Key Advantages:
High Purity Assurance: Consistent quality across batches to support cutting-edge drug development.
Scalable Manufacturing: From lab-scale to commercial production, tailored to customer needs.
Broad Applications: An essential linker widely applied in the synthesis of Semaglutide, Tirzepatide, and other peptide-based innovative drugs.
Global Standards: Manufactured under international regulatory and quality compliance, ensuring reliability and trust.
We are committed to delivering high-quality and reliable raw materials, empowering our partners to advance peptide drug innovation and contribute to global healthcare.
📩 Contact us today and start a new chapter of collaboration!
Prev:
Relevant Information
undefined
